IOL Chemicals Q3 Results: Net profit flat, revenue up 11%; declares interim dividend

Drug firm IOL Chemicals and Pharmaceuticals Ltd on Wednesday (February 11) reported a flat net profit of ₹20.6 crore for the third quarter on a year-on-year basis. Revenue for the quarter rose 11% to ₹580.4 crore, compared with ₹523.3 crore in the corresponding period last year.

The company’s EBITDA increased 22% to ₹57.2 crore, up from ₹47 crore in the year-ago quarter. EBITDA margin stood at 9.9% for the quarter, compared with 8.9% in the same period last year.

Also Read: IOL Chemicals gets EDQM certification for Minoxidil API

The company has declared an interim dividend of ₹1 per equity share of face value ₹2 each, representing 50%, for the financial year 2025-26. The company has fixed February 17, 2026, as the record date to determine the eligibility of shareholders entitled to receive the interim dividend. The payment will be made to eligible shareholders within 30 days of declaration.

The company also reported an exceptional item of ₹11.21 crore in its financial results for the period ended December 31, 2025. The impact arises primarily from changes in the wage definition following the notification of four Labour Codes by the Government of India on November 21, 2025.

Shares of IOL Chemicals and Pharmaceuticals Ltd ended at ₹75.47, down by ₹5.41, or 6.69%, on the BSE.

Also Read: IOL Chem Q2 Results | Net profit jumps 56%, revenue up 8%, margins improve